期刊文献+

光动力疗法治疗肿瘤的免疫机制研究进展 被引量:9

Advances in research on immune mechanism of photodynamic therapy for tumor
原文传递
导出
摘要 光动力疗法(photodynamic therapy,PDT)是治疗肿瘤的有效手段之一,PDT治疗可导致肿瘤细胞的死亡和凋亡,并损伤肿瘤相关血管.近年来,PDT的免疫机制越来越受到关注.肿瘤细胞的免疫逃逸是肿瘤发生发展的重要因素.PDT治疗肿瘤时,可通过免疫原性细胞死亡(immunogenic cell death,ICD)诱导肿瘤细胞表达损伤相关分子模式(damage associated molecular patterns,DAMPs),从而活化树突状细胞,诱导机体特异性抗肿瘤免疫.同时,PDT还可影响肿瘤微环境中的相关免疫细胞和因子,进而增强机体抗肿瘤反应.光动力治疗和其他免疫治疗联合应用亦能增强疗效.故光动力治疗的免疫机制研究将为肿瘤治疗提供可能的新思路. Photodynamic therapy(PDT)is an effective method for the treatment of cutaneous carcinoma,which can cause tumor cell death and apoptosis,and damage tumor-associated blood vessels.In recent years,the immune mechanism of PDT has also received attention.The tumor immune escape in tumorigenesis is an important factor.PDT therapy can induce tumor cells to express damage associated molecular patterns(DAMPs)by immunogenic cell death(ICD),thereby activating dendritic cells(DCs)and inducing anti-tumor adaptive immune responses.At the same time,PDT can affect the relevant immune cells and factors in the tumor microenvironment(TME),thus enhancing the body′s anti-tumor response.The combination of photodynamic therapy and other immunotherapies can also enhance efficacy.Therefore,the research on the immune mechanism of photodynamic therapy will provide possible new ideas for cancer treatment.
作者 薛欢 王佩茹 王秀丽 Xue Huan;Wang Peiru;Wang Xiuli(Shanghai Skin Disease Clinical College of Anhui Medical University,Shanghai 200443,China;Institute of Photomedicine,Shanghai Skin Disease Hospital,Tongji University School of Medicine,Shanghai 200443,China)
出处 《国际免疫学杂志》 CAS 2020年第1期51-55,共5页 International Journal of Immunology
基金 国家自然科学基金(81872212,81872512) 上海市浦江人才计划(17PJ1408500) 中央高校基本科研业务费专项资金资助(221201800101) 上海市卫生计生系统优青计划(2017YQ066)。
关键词 光动力疗法 免疫原性细胞死亡 损伤相关分子模式 肿瘤微环境 Photodynamic therapy Immunogenic cell death Damage associated molecular patterns Tumor microenvironment
  • 相关文献

参考文献2

二级参考文献23

  • 1Sender LY, Gibbert K, Suezer Y, et al. CIM0 ligand-triggered human dendritic ceils mount interleukin-23 responses that are fur- ther enhanced by danger signals. Mol Immunol, 2010, 47 (6) : 1255-1261.
  • 2Villablanca E J, Raccosta L, Zhou D, et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 ex- pression on dendritic cells and dampens antitumor responses. Nat Med, 2010, 16(1) : 98-105.
  • 3Szczepanski MJ, Szajnik M, Czystowska M , et al. Increased fre- quency and suppression by regulatory T ceils in patients with acute myelogenous leukemia. Clin Cancer Res, 2009, 15 ( 10 ) : 3325- 3332.
  • 4Middel P, Bruaneck S, Meyer W, et al. Chemokine-mediated distri- bution of dendritic cell subsets in renal cell carcinoma. BMC Cancer,2010,22(10) :578-580.
  • 5Bronte V, Mocellin S. Suppressive influences in the immune re- sponse to caneer. Immunother, 2009,32 ( 1 ) : 1-11.
  • 6Gigante M, Blasi A, Loverre A, et al. Dysfunctional DC subsets in RCC patients:ex vivo correction to yield an effective anti-cancer vaccine. Mol Immuno1,2009,46 ( 5 ) :893-901.
  • 7Simonetti O, Goteri G, Lucarini G, et al. In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness: An immunohistochemical study. Int J Immunopathol Pharmacol, 2007,20(2) :325-333.
  • 8Ghiringhelli F, Puig PE, Roux S, et al. Tumor ceils convert im- maturemyeloid dendritic ceils into TGF-beta-secreting eells indu-cing CIM + CD25 + regulatory T cell proliferation. J Exp Med, 2005, 202(7) :919-929.
  • 9Gerner MY,Mescher MF. Antigen processing and MHC-II presen- tation by dermal and tumor-infiltrating dendritic cells. Immunol, 2009,182 ( 5 ) :2726-2737.
  • 10Chiang CL, Benencia F, Coukos G. Whole tumor antigen vac- cines. Semin in Immuno1,2010,22 ( 3 ) : 132-143.

共引文献22

同被引文献86

引证文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部